RVMD Revolution Medicines, Inc.
Revolution Medicines, Inc. (RVMD) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 98% planned / 2% discretionary
Largest single sale: $18.0M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Kim Lorence H. 7 fills | Director | Sell 10b5-1 | 17,090 | $209.82 | $3.6M | 16,384 −51.1% of holding | |
| Kim Lorence H. 7 fills | Director | Sell 10b5-1 | 56,000 | $203.24 | $11.4M | 72,790 −43.5% of holding | |
| GOLDSMITH MARK A 6 fills | See Remarks | Sell 10b5-1 | 80,000 | $209.20 | $16.7M | 342,202 −18.9% of holding | |
| Cislini Jeff 6 fills | General Counsel | Sell 10b5-1 | 56,894 | $209.24 | $11.9M | 109,401 −34.2% of holding | |
| GOLDSMITH MARK A 12 fills | See Remarks | Sell | 6,000 | $209.20 | $1.3M | 64,247 −8.5% of holding | |
| Patel Sushil 9 fills | Director | Sell 10b5-1 | 5,580 | $187.99 | $1.0M | 26,936 −17.2% of holding | |
| Anders Jack 4 fills | Chief Financial Officer | Sell 10b5-1 | 20,000 | $168.33 | $3.4M | 138,716 −12.6% of holding | |
| Horn Margaret A | Chief Operating Officer | Sell 10b5-1 | 29,600 | $160.12 | $4.7M | 154,647 −16.1% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 10,020 | $156.12 | $1.6M | 267,330 −3.6% of holding | |
| Mancini Anthony | See Remarks | Sell | 4,615 | $156.12 | $720.5K | 49,975 −8.5% of holding | |
| Kelsey Stephen Michael | See Remarks | Sell 10b5-1 | 4,175 | $156.12 | $651.8K | 291,876 −1.4% of holding | |
| Anders Jack | Chief Financial Officer | Sell 10b5-1 | 2,722 | $156.12 | $425.0K | 123,269 −2.2% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 2,157 | $156.12 | $336.7K | 56,521 −3.7% of holding | |
| Horn Margaret A | Chief Operating Officer | Sell 10b5-1 | 60,400 | $160.17 | $9.7M | 158,222 −27.6% of holding | |
| Horn Margaret A 7 fills | Chief Operating Officer | Sell 10b5-1 | 10,000 | $148.01 | $1.5M | 166,907 −5.7% of holding | |
| Mancini Anthony 3 fills | See Remarks | Sell 10b5-1 | 3,121 | $153.99 | $480.6K | 56,821 −5.2% of holding | |
| Mancini Anthony 3 fills | See Remarks | Sell 10b5-1 | 3,120 | $132.41 | $413.1K | 55,849 −5.3% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 120,000 | $150.09 | $18.0M | 276,698 −30.2% of holding | |
| Mancini Anthony 5 fills | See Remarks | Sell 10b5-1 | 37,450 | $95.56 | $3.6M | 90,050 −29.4% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 1,163 | $97.44 | $113.3K | 58,518 −1.9% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 12,871 | $99.48 | $1.3M | 276,698 −4.4% of holding | |
| Horn Margaret A | Chief Operating Officer | Sell 10b5-1 | 4,583 | $99.48 | $455.9K | 157,570 −2.8% of holding | |
| Kelsey Stephen Michael | See Remarks | Sell 10b5-1 | 4,302 | $99.48 | $428.0K | 295,398 −1.4% of holding | |
| Anders Jack | Chief Financial Officer | Sell 10b5-1 | 2,753 | $99.48 | $273.9K | 125,512 −2.1% of holding | |
| Wei Lin | Chief Medical Officer | Sell 10b5-1 | 2,073 | $99.48 | $206.2K | 101,366 −2% of holding | |
| Wang Xiaolin | See Remarks | Sell 10b5-1 | 2,010 | $99.48 | $200.0K | 116,063 −1.7% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 1,795 | $99.48 | $178.6K | 59,681 −2.9% of holding | |
| GOLDSMITH MARK A 5 fills | See Remarks | Sell 10b5-1 | 30,000 | $101.22 | $3.0M | 318,869 −8.6% of holding | |
| GOLDSMITH MARK A 8 fills | See Remarks | Sell | 6,000 | $101.30 | $607.8K | 67,324 −8.2% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 908 | $115.60 | $105.0K | 46,976 −1.9% of holding | |
| Horn Margaret A 3 fills | Chief Operating Officer | Sell 10b5-1 | 75,000 | $100.56 | $7.5M | 162,957 −31.5% of holding | |
| Anders Jack | Chief Financial Officer | Sell 10b5-1 | 10,000 | $98.00 | $980.0K | 108,065 −8.5% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 15,394 | $76.82 | $1.2M | 232,469 −6.2% of holding | |
| Kelsey Stephen Michael | See Remarks | Sell 10b5-1 | 5,447 | $76.82 | $418.4K | 278,600 −1.9% of holding | |
| Horn Margaret A | Chief Operating Officer | Sell 10b5-1 | 4,847 | $76.82 | $372.3K | 141,053 −3.3% of holding | |
| Anders Jack | Chief Financial Officer | Sell 10b5-1 | 3,104 | $77.09 | $239.3K | 108,065 −2.8% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 2,688 | $76.82 | $206.5K | 47,884 −5.3% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 60,000 | $75.08 | $4.5M | 247,863 −19.5% of holding | |
| GOLDSMITH MARK A 2 fills | See Remarks | Sell | 6,000 | $75.00 | $450.0K | 67,424 −8.2% of holding | |
| Anders Jack | Chief Financial Officer | Sell 10b5-1 | 5,418 | $74.00 | $400.9K | 110,994 −4.7% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 20,000 | $70.38 | $1.4M | 247,863 −7.5% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 13,388 | $70.14 | $939.0K | 50,425 −21% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 20,000 | $65.07 | $1.3M | 247,863 −7.5% of holding | |
| Anders Jack | Chief Financial Officer | Sell 10b5-1 | 10,000 | $64.00 | $640.0K | 110,994 −8.3% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 30,000 | $60.31 | $1.8M | 347,863 −7.9% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 12,000 | $55.00 | $660.0K | 50,425 −19.2% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 10,000 | $55.00 | $550.0K | 452,309 −2.2% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 10,000 | $50.47 | $504.7K | 452,309 −2.2% of holding | |
| Kelsey Stephen Michael | See Remarks | Sell 10b5-1 | 25,000 | $48.54 | $1.2M | 284,047 −8.1% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 1,799 | $44.26 | $79.6K | 50,425 −3.4% of holding | |
| GOLDSMITH MARK A | See Remarks | Sell 10b5-1 | 13,411 | $45.82 | $614.6K | 452,309 −2.9% of holding | |
| Kelsey Stephen Michael | See Remarks | Sell 10b5-1 | 5,367 | $45.82 | $245.9K | 284,047 −1.9% of holding | |
| Horn Margaret A | Chief Operating Officer | Sell 10b5-1 | 4,775 | $45.82 | $218.8K | 145,900 −3.2% of holding | |
| Anders Jack | Chief Financial Officer | Sell 10b5-1 | 2,320 | $45.82 | $106.3K | 110,994 −2% of holding | |
| Wei Lin | Chief Medical Officer | Sell 10b5-1 | 2,160 | $45.82 | $99.0K | 88,339 −2.4% of holding | |
| Cislini Jeff | General Counsel | Sell 10b5-1 | 1,869 | $45.82 | $85.6K | 52,224 −3.5% of holding | |
| Kelsey Stephen Michael 2 fills | See Remarks | Sell 10b5-1 | 25,000 | $45.97 | $1.1M | 290,732 −7.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.